Instead of attacking tumor cells directly, as some treatments would, the goal of immunotherapy is to “wake up” the immune system and help it recognize these cells and destroy them.
Focus on CAR-Ts
#ExploreForCancer focuses on CAR-Ts, a unique form of cellular immunotherapy for each patient that is among the latest innovations in cancer treatment.
This strategy consists of taking and then modifying the patient’s immune cells (T lymphocytes) to rearm them against the tumour. These cells are then multiplied in the laboratory and then reinjected in large quantities into the patient’s body where they are once again able to destroy cancer cells. A source of hope, especially for certain blood cancers.
#ExploreForCancer: everyone can help support cancer research
This 4th edition of #ExploreForCancer will be held in Montpellier. A structure hosting an educational space as well as a digital, immersive and artistic representation of the awakening of the immune system will be installed Place de la Comédie from September 24 to 28, 2022. The floor will also be given to patients who are members of the AF3M associations (Association Française des Malades multiple myeloma) and My network® lung cancer so that they can discuss and testify about their journey.
If you can’t come, a “digital” version will also be available on the website www.exploreforcancer.fr. Thus, each French person will be able to contribute to supporting public research by sharing the hashtag #ExploreForCancer on their social networks. For each visit or sharing, Bristol Myers Squibb undertakes to pay €1 to the Cancer Research Institute of Montpellier (IRCM) with the aim of reaching €200,000 to finance the project carried out by the teams of researchers from the Doctors Nathalie Bonnefoy and Laurent Le Cam. “It is the understanding of the dialogue between cancer cells and immune cells within tumors that has revolutionized cancer treatment with the advent of immunotherapies”, underlines Dr. Nathalie Bonnefoy, research director at INSERM and Head of the “Immunity and Cancer” team. “Our challenge now is to finely dissect these interactions to better understand the mechanisms of immune cell inactivation by tumor cells. »
Insomnia would increase the risk of cognitive decline